Clearstead Advisors’s Shattuck Labs STTK Stock Holding History

Clearstead Advisors’s Portfolio STTK Stock Details STTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-155	Closed	-$123	–	3242
2025 Q2	$123	Buy	+155	New	+$150	﹤0.01%	2598

Other funds holding STTK

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

CEI

Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Clearstead Advisors's STTK Position: Q3 2025 in Review

Clearstead Advisors sold out of Shattuck Labs (STTK) in Q3 2025, closing a stake of 155 shares — an estimated $123 sold.

Clearstead Advisors first reported a position in STTK in Q2 2025 and held it in 1 quarter. The position peaked at $123 in Q2 2025. 56 funds tracked by Wall St. Rank hold STTK as of Q3 2025.

Clearstead Advisors reported no remaining Shattuck Labs position as of Q3 2025 after selling out during the quarter.
Clearstead Advisors sold 155 Shattuck Labs shares in Q3 2025, an estimated $123.
Clearstead Advisors first reported a position in Shattuck Labs in Q2 2025 and held it in 1 quarter.
Clearstead Advisors's Shattuck Labs position peaked at $123 in Q2 2025.
56 funds tracked by Wall St. Rank held Shattuck Labs as of Q3 2025.

Based on Clearstead Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.